Evidence map›Paper›PMID 19286996›Full record

ArticleBlood2009

microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells.

R Patrick Weitzel, Mathew L Lesniewski, Peter Haviernik, Suzanne Kadereit, Patrick Leahy, Nicholas J Greco, Mary J Laughlin

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Unveiling the hemolymphatic miRNome composition of the schistosomiasis vector snailCurrent research in parasitology & vector-borne diseases · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

R Patrick WeitzelDepartment of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Mathew L Lesniewski
Peter Haviernik
Suzanne Kadereit
Patrick Leahy
Nicholas J Greco
Mary J Laughlin
Case Comprehensive Cancer CenterCase Western Reserve University · USUniversity of Konstanz · DE

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Drew James Adams · 1987 to 2026
$142.3M
RESEARCH ONCOLOGY TRAINING GRANTT32CA059366 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JACKSON, MARK W. · 1993 to 2025
$5.5M
MECHANISMS UNDERLYING GRAFT-VERSUS-HOST DISEASER01AI047289 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LAUGHLIN, MARY J · 2000 to 2004
$1.3M
NCI NIH HHS 5P30 CA043703NCI NIH HHS 5T32-CA059366-13NCI NIH HHS P30 CA043703NCI NIH HHS T32 CA059366NIAID NIH HHS R01 AI047289NIAID NIH HHS R01-AI47289-01
6 · The paper itself

Abstract

The reduced expression of nuclear factor of activated T cells-1 (NFAT1) protein in umbilical cord blood (UCB)-derived CD4+ T cells and the corresponding reduction in inflammatory cytokine secretion after stimulation in part underlies their phenotypic differences from adult blood (AB) CD4+ T cells. This muted response may contribute to the lower incidence and severity of high-grade acute graft-versus-host disease (aGVHD) exhibited by UCB grafts. Here we provide evidence that a specific microRNA, miR-184, inhibits NFAT1 protein expression elicited by UCB CD4+ T cells. Endogenous expression of miR-184 in UCB is 58.4-fold higher compared with AB CD4+ T cells, and miR-184 blocks production of NFAT1 protein through its complementary target sequence on the NFATc2 mRNA without transcript degradation. Furthermore, its negative effects on NFAT1 protein and downstream interleukin-2 (IL-2) transcription are reversed through antisense blocking in UCB and can be replicated via exogenous transfection of precursor miR-184 into AB CD4+ T cells. Our findings reveal a previously uncharacterized role for miR-184 in UCB CD4+ T cells and a novel function for microRNA in the early adaptive immune response.

Indexed as

Gene Expression Regulation, Developmental3' Untranslated RegionsAdultAge FactorsBinding SitesCD4-Positive T-LymphocytesFetal BloodHumansInfant, NewbornInterleukin-2Lymphocyte ActivationMicroRNAsNFATC Transcription FactorsRNA, Messenger3' Untranslated RegionsInterleukin-2MicroRNAsMIRN184 microRNA, humanNFATC2 protein, humanNFATC Transcription FactorsRNA, Messenger

Identifiers

PMID19286996
PMCPMC2710921
OpenAlexW2043251840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.